Kinouani, Shérazade
Macalli, Mélissa
Arsandaux, Julie
Montagni, Ilaria
Texier, Nathalie
Schück, Stéphane
Tzourio, Christophe
Funding for this research was provided by:
Université de Bordeaux
Conseil Régional Nouvelle-Aquitaine/ PhD Grant (17-EURE-0019)
Kap Code
Kappa Santé CRO
Article History
Received: 30 March 2023
Accepted: 22 February 2024
First Online: 29 February 2024
Declarations
:
: The Confins cohort followed the principles of the Declaration of Helsinki, and the collection, storage, and analysis of the data complied with the General Data Protection Regulation (EU GDPR). The study was approved by a French Committee for the Protection of Individuals (<i>Comité de Protection des Personnes</i>—CPP, nr. 46–2020) for studies involving humans. In France, the Committee for the Protection of Individuals is the Ethics Committee for Biomedical Research (clinical trials or observational studies) involving human subjects. It approved the present study. The study was also approved by the National Commission on Informatics and Liberty (<i>Commission Nationale de l'Informatique et des Libertés</i>—CNIL, nr. MLD/MFI/AR205600).An information note was available online on the study website; it was mandatory to read it and tick the consent to participate before accessing the questionnaire. Therefore, electronic informed consent was obtained from all subjects involved in the study. Then, the survey was anonymous. This consent method was approved by the French Committee for the Protection of Individuals.
: Not applicable.
: The authors declare no competing interests.